Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MD1003 in Adrenomyeloneuropathy : a Randomized Double Blind Placebo Controlled Study

NCT02961803 is registered in ClinicalTrials.gov with MedDay Pharmaceuticals SA as lead sponsor.

NCT NCT02961803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02961803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MD1003 in Adrenomyeloneuropathy : a Randomized Double Blind Placebo Controlled Study
Lead sponsor
MedDay Pharmaceuticals SA
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2014
Completion date
June 30, 2017
Enrollment
67 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adrenoleukodystrophy, adrenomyeloneuropathy, amn